There are 2789 resources available
Yes
Presenter: Heather Wakelee
Session: Are we ready to consider chemotherapy + checkpoint inhibitor as the preferred option in the neoadjuvant setting?
Resources:
Slides
Webcast
No
Presenter: Martin Reck
Session: Are we ready to consider chemotherapy + checkpoint inhibitor as the preferred option in the neoadjuvant setting?
Resources:
Slides
Webcast
Polling 2 (led by chair)
Presenter: Nicolas Girard
Session: Are we ready to consider chemotherapy + checkpoint inhibitor as the preferred option in the neoadjuvant setting?
Resources:
Slides
Webcast
Q&A
Presenter: Nicolas Girard
Session: Are we ready to consider chemotherapy + checkpoint inhibitor as the preferred option in the neoadjuvant setting?
Resources:
Slides
Webcast
Real-world experience using the ESMO-MCBS in clinical practice
Presenter: Barbara Kiesewetter-Wiederkehr
Session: Does my patient really benefit from my treatment? Physician, patient and value perspectives
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Michiel Strijbos
Session: Does my patient really benefit from my treatment? Physician, patient and value perspectives
Resources:
Slides
Webcast
Introduction
Presenter: E.G. Elisabeth de Vries
Session: WHO access to meaningful medicines
Resources:
Webcast
Access to relevant drugs in LMICs
Presenter: Bishal Gyawali
Session: WHO access to meaningful medicines
Resources:
Slides
Webcast
The ten cancer therapeutics that front-line cancer physicians find most essential
Presenter: Christopher Booth
Session: WHO access to meaningful medicines
Resources:
Slides
Webcast
Role of cancer drugs on WHO EML
Presenter: Lorenzo Moja
Session: WHO access to meaningful medicines
Resources:
Slides
Webcast